| pubmed-article:16770258 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C0040866 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:16770258 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:16770258 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16770258 | pubmed:dateCreated | 2006-6-13 | lld:pubmed |
| pubmed-article:16770258 | pubmed:abstractText | The safety and pharmacokinetics of a triamcinolone acetonide (TA) preservative-free (TA-PF) formulation were investigated after intravitreal administration in rabbits. | lld:pubmed |
| pubmed-article:16770258 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16770258 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16770258 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16770258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16770258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16770258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16770258 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16770258 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16770258 | pubmed:issn | 0275-004X | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:CsakyKarl GKG | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:LutzRobert... | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:BungayPeter... | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:RobinsonMicha... | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:YuanPengP | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:KimHyuncheolH | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:GravlinLuisaL | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:TanseyGingerG | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:GrimesGeorgeG | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:PottiGopal... | lld:pubmed |
| pubmed-article:16770258 | pubmed:author | pubmed-author:DE... | lld:pubmed |
| pubmed-article:16770258 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16770258 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:16770258 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16770258 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16770258 | pubmed:pagination | 523-30 | lld:pubmed |
| pubmed-article:16770258 | pubmed:dateRevised | 2006-12-15 | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:meshHeading | pubmed-meshheading:16770258... | lld:pubmed |
| pubmed-article:16770258 | pubmed:articleTitle | Safety and pharmacokinetics of a preservative-free triamcinolone acetonide formulation for intravitreal administration. | lld:pubmed |
| pubmed-article:16770258 | pubmed:affiliation | National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA. | lld:pubmed |
| pubmed-article:16770258 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16770258 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16770258 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16770258 | lld:pubmed |
